Log in

Relevant bibliographies by topics / Disease prevention / Journal articles

To see the other types of publications on this topic, follow the link: Disease prevention.

Journal articles on the topic 'Disease prevention'

Author: Grafiati

Published: 4 June 2021

Last updated: 29 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Disease prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Shakhnoza, Iskandarova, and Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE." American Journal of Medical Sciences and Pharmaceutical Research 04, no. 04 (April 1, 2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Full text

Abstract:

Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.

APA, Harvard, Vancouver, ISO, and other styles

2

&NA;. "DISEASE PREVENTION." American Journal of Nursing 99, no. 8 (August 1999): 10. http://dx.doi.org/10.1097/00000446-199908000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pignone, Michael P., and Kirsten Bibbins-Domingo. "Disease Prevention." Medical Clinics of North America 101, no. 4 (July 2017): i. http://dx.doi.org/10.1016/s0025-7125(17)30070-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Shubrook, Jay H. "Disease prevention." Osteopathic Family Physician 3, no. 5 (September 2011): 181. http://dx.doi.org/10.1016/j.osfp.2011.07.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Selby, JoeV. "DISEASE PREVENTION." Lancet 341, no. 8847 (March 1993): 728–29. http://dx.doi.org/10.1016/0140-6736(93)90493-z.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

SCHAPIRA, DAVID V. "Disease Prevention." Archives of Internal Medicine 149, no. 6 (June 1, 1989): 1253. http://dx.doi.org/10.1001/archinte.1989.00390060007001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Zuo, Tongzhuo. "The Current Status of Occupational Disease Prevention." Learning & Education 9, no. 2 (November 10, 2020): 6. http://dx.doi.org/10.18282/l-e.v9i2.1385.

Full text

Abstract:

Occupational diseases are disorders of health resulting from conditions related to the workplace. There are 2.3 million deaths annually for reasons attributed to work globally, primarily to chemicals or dust. China has the largest working population in the world, with 776 million employed in 2018. According to the National Health Commission, about 12 million companies were found to have occupational-disease-inductive factors and at least 200 million people are exposed to occupational disease hazards. Preventing occupational diseases is a serious worldwide challenge. On the other hand, many developed countries already have rich experience in the prevention and treatment of various occupational diseases. They have set up various occupational disease prevention agencies and formulated strict occupational disease prevention systems. It is necessary for developing countries to learn from their advanced control measures.

APA, Harvard, Vancouver, ISO, and other styles

8

Mirzakarimova, Farida, Svetlana Kaleda, Natalia Polikarpova, and Abdumurad Babadjanov. "NONALCOHOLIC FATTY LIVER DISEASE -SOME ASPECTS OF PREVENTION." UZBEK MEDICAL JOURNAL 2, no. 2 (February 28, 2021): 15–24. http://dx.doi.org/10.26739/2181-0664-2021-2-3.

Full text

Abstract:

Nowadays, NAFLD is considered one of the leading causes of chronic liver diseases globally.This is probably becausea patient with NAFLD usually had more severe diseases -diabetes mellitus type 2 (DM-2), metabolic syndrome, etc. On the one hand, after it was established that insulin resistance underlies these metabolic diseases and, on the other hand, that compensationfor these conditions does not eliminate NAFLD, and the presence of NAFLD worsens the course of the underlying disease, interest in its study increased significantly. The development of NAFLD is increasingly associated with the hypothesis of multifactorial parallel effects, or "multiple parallel hits" ("multiple parallel hits").

APA, Harvard, Vancouver, ISO, and other styles

9

Maeda, Kazuo. "Prevention of Choriocarcinoma after Postmolar Persistent Trophoblastic Disease." Women Health Care and Issues 2, no. 2 (December 10, 2019): 01. http://dx.doi.org/10.31579/2642-9756/009.

Full text

Abstract:

Also Chemotherapy was progresses in choriocarcinoma after Methotrexate, still its prevention with the treatment of persistent trophoblastic dusase is needed after molar treatment.The prevention was achieved with particular MTX treatment of persistenttrophoblastic disease.

APA, Harvard, Vancouver, ISO, and other styles

10

Aslam, Dr Imran, Yuldashev Soatboy Jiyanboyevich, and Abdurakhmanova Zamira Ergashboevna. "Prevention & Treatment Of Cardiovascular Diseases." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 06 (June 10, 2021): 180–88. http://dx.doi.org/10.37547/tajmspr/volume03issue06-28.

Full text

Abstract:

Cardiovascular disease is a significant problem that humans have always faced, affecting thousands of people's lives and health and taking the lives of many people. Many medical institutions and researchers have regarded it as a significant problem in overcoming the cardiovascular disease.1 Much attention has been paid, so the prevention and treatment level in this area has also been rapidly improved. However, cardiovascular disease still cannot be prevented or treated fundamentally, and it is still a significant danger to human health. All people still hope for breakthrough results in cardiovascular disease.2 This article analyzes the prevention and treatment of cardiovascular diseases, and has obtained a series of practical and reliable conclusions.

APA, Harvard, Vancouver, ISO, and other styles

11

Pipe, Andrew. "Cardiovascular disease prevention." Current Opinion in Cardiology 33, no. 5 (September 2018): 498–99. http://dx.doi.org/10.1097/hco.0000000000000551.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Van Camp, G. "Cardiovascular disease prevention." Acta Clinica Belgica 69, no. 6 (August 31, 2014): 407–11. http://dx.doi.org/10.1179/2295333714y.0000000069.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Schargrodsky, Herman, María C. Escobar, and Edgardo Escobar. "Cardiovascular Disease Prevention." Circulation 98, no. 20 (November 17, 1998): 2103–4. http://dx.doi.org/10.1161/01.cir.98.20.2103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Rendall, G. "Bee disease prevention." Veterinary Record 122, no. 13 (March 26, 1988): 311–12. http://dx.doi.org/10.1136/vr.122.13.311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Kapustin, Jane. "Chronic Disease Prevention." Journal for Nurse Practitioners 6, no. 1 (January 2010): 6. http://dx.doi.org/10.1016/j.nurpra.2009.09.017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Keevil, Jon G., James H. Stein, and Patrick E. McBride. "Cardiovascular disease prevention." Primary Care: Clinics in Office Practice 29, no. 3 (September 2002): 667–96. http://dx.doi.org/10.1016/s0095-4543(02)00012-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Burns, Jackie. "Pneumococcal disease prevention." Primary Health Care 12, no. 8 (October 2002): 24–26. http://dx.doi.org/10.7748/phc.12.8.24.s21.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Dietz, William H., Clifford E. Douglas, and Ross C. Brownson. "Chronic Disease Prevention." JAMA 316, no. 16 (October 25, 2016): 1645. http://dx.doi.org/10.1001/jama.2016.14370.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Pawar, Neha madhukar, and Archana Kulkarni. "CONCEPT OF VYADHIKSHAMATVA IN AYRVEDA." International Journal of Research -GRANTHAALAYAH 8, no. 8 (August 30, 2020): 239–43. http://dx.doi.org/10.29121/granthaalayah.v8.i8.2020.1064.

Full text

Abstract:

For prevention of diseases, Ayurveda had advocated the adherence to concepts like dina charya, ritu charya, sadvritta , Na vega dharan etc. these measures are useful in preventing the lifestyle related diseases but for preventing the Aupsargik rogas (communicable diseases), Janapada dhwansa rogas (epidemic diseases), Krumij Roga (Infectious diseases), Asatmyaj roga (allergic disorders), the concept of Vyadhikshamtva (Immunity) is propagated by the Ayurvedic science [1]. According to the concept of Ojas or Vyadhikshamatva or Bala (immunity), the body‟s resistance is of tremendous importance in the daily welfare of living beings not only for disease prevention but also for rapid recovery after disease affliction. [2] Ayurveda propounds that prevention is an equally important aspect of disease management as cure and thus, strengthening the immune system, is a natural way to help the body fight against the disease-causing pathogens. Acharyas promoted the use of Rasayana (Rejuvenation) to enhance ojas and vyadhikshamatva (immunity). This article is an effort to present Ayurvedic concepts of Vyadhishamatva.

APA, Harvard, Vancouver, ISO, and other styles

20

Turner, Chris. "Prevention, prevention." Faculty Dental Journal 10, no. 3 (July 2019): 94–97. http://dx.doi.org/10.1308/rcsfdj.2019.94.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

O'g'li, Roxibjonov Adhamjon Raxmatjon. "PREVENTION OF DILATED CARDIOMYOPATHY DISEASE MEASURES TO TREAT IT." International Journal of Medical Sciences And Clinical Research 3, no. 12 (December 1, 2023): 13–18. http://dx.doi.org/10.37547/ijmscr/volume03issue12-03.

Full text

Abstract:

Dilated cardiomyopathy is myocardial dysfunction causing heart failure in which ventricular dilation and systolic dysfunction predominate. Symptoms include dyspnea, fatigue, and peripheral edema. Diagnosis is clinical and by elevated natriuretic peptides, chest x-ray, echocardiography, and MRI. Treatment is directed at the cause. If heart failure is progressive and severe, cardiac resynchronization therapy, implantable cardioverter-defibrillator, repair of moderate to severe valvular regurgitation, left ventricular assist device, or heart transplantation may be needed.

APA, Harvard, Vancouver, ISO, and other styles

22

Najmitdinovna, Kudratova Gulsara, and Ibragimova Yulduz Botyrovna. "PREVENTION OF BRONCHIAL ASTHMA IN CHILDREN AND TEENAGERS." American Journal Of Biomedical Science & Pharmaceutical Innovation 4, no. 3 (March 1, 2024): 52–55. http://dx.doi.org/10.37547/ajbspi/volume04issue03-07.

Full text

Abstract:

Bronchial asthma is considered a chronic disease and causes many health problems for the population. The disease is based on a genetic predisposition. Children whose parents have allergic diseases (bronchial asthma, allergic rhinitis, atopic dermatitis, eczema, Quincke's edema, etc.) have asthma in the first year of life the tendency to develop the disease is high. (25% if father or mother is sick with allergic diseases, 50% if allergic diseases are observed in both father and mother).

APA, Harvard, Vancouver, ISO, and other styles

23

Fugh-Berman, A., and S. Epstein. "Tamoxifen: disease prevention or disease substitution?" Lancet 340, no. 8828 (November 1992): 1143–45. http://dx.doi.org/10.1016/0140-6736(92)93161-f.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Berra, K., N. Houston Miller, and J. M. Fair. "Cardiovascular Disease Prevention and Disease Management." Journal of Cardiopulmonary Rehabilitation 26, no. 4 (July 2006): 197–206. http://dx.doi.org/10.1097/00008483-200607000-00001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Dmochowski, Tymon. "Green infrastructure as a disease prevention and rehabilitation tool." Przegląd Naukowy Inżynieria i Kształtowanie Środowiska 28, no. 4 (December 29, 2019): 682–89. http://dx.doi.org/10.22630/pniks.2019.28.4.61.

Full text

Abstract:

This article tackles with the problem of preventing diseases caused by physical inactivity. It offers a brief review of deadliest diseases and defi nes critical role of green public spaces in their prevention. Article presents patient treatment costs, in contrast to the costs of organizing green public spaces, suggesting substantial relief from economic burden sustained by national health fund by offering green public spaces designed specifi cally for disease prevention instead of conventional treatment.

APA, Harvard, Vancouver, ISO, and other styles

26

Vakrilova Becheva, Maria Stamova, Angelina Georgieva Kirkova-Bogdanova, Stefka Аchkova Ivanova, Petar Jordanov Atanasov, Mariya Sevdelinova Chaneva, and Valentina Boyanova Petkova. "Prevention of cardiovascular diseases." Pharmacia 70, no. 4 (October 27, 2023): 1243–47. http://dx.doi.org/10.3897/pharmacia.70.e114071.

Full text

Abstract:

Cardiovascular diseases (CVD) are socially significant diseases due to high morbidity and loss of people of working age. In Bulgaria, they are the leading cause of mortality among the population and are a consequence of the effect of cardiovascular risk factors. The draft of the National Health Strategy (NHS) 2021–2030 reports on their wide distribution, as well as on the insufficient knowledge, skills and motivation for their prevention and control. The purpose of this review is to address the prevention of cardiovascular disease, which is a significant problem worldwide. Prevention goals for patients with established cardiovascular disease and those at high risk include smoking cessation, healthy eating, physical activity, and lowering body mass index. There are various methods that are part of health promotion to reduce CVD risks. These methods include motivational interviewing, non-pharmacological means, the use of certain medications for CVD prevention, as well as physical activity. Strategies for effective primary prevention refer to engaging the patient to change their lifestyle and identifying risk factors, while secondary prevention is aimed at activities to detect the disease early and to slow down its progression. It is necessary to create a strategy for timely preventive actions with a view to preventing the negative influence of risk factors and improving people‘s heart health.

APA, Harvard, Vancouver, ISO, and other styles

27

Chew, Emily Y. "Disease Management by Prevention." Disease Management and Health Outcomes 6, no. 5 (1999): 279–90. http://dx.doi.org/10.2165/00115677-199906050-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Traynor, Kate. "Disease prevention gains attention." American Journal of Health-System Pharmacy 66, no. 15 (August 1, 2009): 1336–38. http://dx.doi.org/10.2146/news090063.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Lavie, Carl J., Ray W. Squires, and Gerald T. Gau. "Prevention of cardiovascular disease." Postgraduate Medicine 81, no. 5 (April 1987): 52–72. http://dx.doi.org/10.1080/00325481.1987.11699780.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Tenenbaum, Ariel, Mohammed Morad, and Joav Merrick. "Cardiovascular disease and prevention." International Journal of Adolescent Medicine and Health 26, no. 4 (November 1, 2014): 457–58. http://dx.doi.org/10.1515/ijamh-2014-0004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Bauer, Michael, and Dominic Coppolo. "Agricultural Lung Disease: Prevention." Seminars in Respiratory and Critical Care Medicine 14, no. 01 (January 1993): 83–89. http://dx.doi.org/10.1055/s-2007-1006311.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Coralli, Connie. "Disease Prevention/Health Promotion." Nurse Practitioner 15, no. 2 (February 1990): 74. http://dx.doi.org/10.1097/00006205-199002000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Gardner, Pierce. "Prevention of Meningococcal Disease." New England Journal of Medicine 355, no. 14 (October 5, 2006): 1466–73. http://dx.doi.org/10.1056/nejmcp063561.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Kornhuber, J. "Prevention of Alzheimer's Disease." Fortschritte der Neurologie · Psychiatrie 73, no. 6 (June 2005): 315–16. http://dx.doi.org/10.1055/s-2004-830309.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Filley, Christopher M. "Alzheimer disease prevention: Table." Neurology: Clinical Practice 5, no. 3 (December 29, 2014): 193–200. http://dx.doi.org/10.1212/cpj.0000000000000108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Zimmerman, Marcia. "Phytochemicals and Disease Prevention." Alternative and Complementary Therapies 1, no. 3 (April 1995): 154–57. http://dx.doi.org/10.1089/act.1995.1.154.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Szekely, C. A., J. C. S. Breitner, and P. P. Zandi. "Prevention of Alzheimer's disease." International Review of Psychiatry 19, no. 6 (January 2007): 693–706. http://dx.doi.org/10.1080/09540260701797944.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Thal, Leon J. "Prevention of Alzheimer Disease." Alzheimer Disease & Associated Disorders 20, Supplement 2 (July 2006): S97—S99. http://dx.doi.org/10.1097/00002093-200607001-00015.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Bloomgarden, Z. T. "Prevention of Cardiovascular Disease." Diabetes Care 30, no. 2 (January 26, 2007): 423–31. http://dx.doi.org/10.2337/dc07-zb02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

&NA;. "Prevention of heart disease." Inpharma Weekly &NA;, no. 833 (April 1992): 3. http://dx.doi.org/10.2165/00128413-199208330-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Paixao, Andre R. M., Colby R. Ayers, Jarett D. Berry, James A. de Lemos, and Amit Khera. "Atherosclerotic Cardiovascular Disease Prevention." Circulation: Cardiovascular Quality and Outcomes 7, no. 5 (September 2014): 778–79. http://dx.doi.org/10.1161/circoutcomes.114.001139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Holmes, Julia S., Irma E. Arispe, and Ernest Moy. "Heart Disease and Prevention." Medical Care 43, Supplement (March 2005): I—33—I—41. http://dx.doi.org/10.1097/00005650-200503001-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Porena, M., P. Guiggi, and C. Micheli. "Prevention of Stone Disease." Urologia Internationalis 79, no. 1 (2007): 37–46. http://dx.doi.org/10.1159/000104440.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Couch, Patricia, and Gary E. Johnson. "Prevention of Lyme disease." American Journal of Health-System Pharmacy 49, no. 5 (May 1, 1992): 1164–73. http://dx.doi.org/10.1093/ajhp/49.5.1164.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

King, Kathryn M., and Heather M. Arthur. "Coronary Heart Disease Prevention." Journal of Cardiovascular Nursing 18, no. 4 (September 2003): 274–81. http://dx.doi.org/10.1097/00005082-200309000-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Hill, Martha N., and George A. Mensah. "Global Cardiovascular Disease Prevention." Journal of Cardiovascular Nursing 26, Supplement (July 2011): S4. http://dx.doi.org/10.1097/jcn.0b013e318213efe4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Berra, Kathy, Barbara Fletcher, Laura L. Hayman, and Nancy Houston Miller. "Global Cardiovascular Disease Prevention." Journal of Cardiovascular Nursing 28, no. 6 (2013): 505–13. http://dx.doi.org/10.1097/jcn.0b013e31826b6822.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Schafer, Tara E., and Steven M. Adair. "PREVENTION OF DENTAL DISEASE." Pediatric Clinics of North America 47, no. 5 (October 2000): 1021–42. http://dx.doi.org/10.1016/s0031-3955(05)70256-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Rose, Geoffrey, M. P. H. Doublet Stewart, ChristopherA Birt, PeterR Croft, and PatrickF James. "CORONARY HEART DISEASE PREVENTION." Lancet 332, no. 8619 (November 1988): 1081–82. http://dx.doi.org/10.1016/s0140-6736(88)90102-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Mccormick, JamesS, Petr Skrabanek, J. A. Lee, and R. C. Cottrell. "CORONARY HEART DISEASE PREVENTION." Lancet 332, no. 8621 (November 1988): 1189–90. http://dx.doi.org/10.1016/s0140-6736(88)90252-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!